RxDoctor Payments Data

Yadwinder Dhillon, MD

Family Medicine · Mesa, AZNPI 1609052430

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,798 of the $5,954 with a category attached, or 63.8%. 29 manufacturers reported payments, led by Triad Life Sciences Inc. at 43.5% of the total. Reporting peaked in 2022 at $2,821 and has fallen 62.0% since, to $1,073 in 2025. Among family medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,954in general payments, 2019–2025

Across 122 payments — averaging $48.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Triad Life Sciences Inc.$3K
  • Smith+Nephew$848
  • Musculoskeletal Transplant Foundation Inc.$500
  • Urgo Medical North America, LLC$416
  • Mimedx Group, Inc.$380
  • Stryker$162
  • plus $1K from 23 others
$441,365in research payments, 2019–2025

Across 66 payments — averaging $6687.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$244K
  • Teva Pharmaceuticals USA, Inc.$80K
  • Osiris Therapeutics Inc.$62K
  • Mallinckrodt Hospital Products Inc.$28K
  • Kadmon Corporation LLC$25K
  • Glenmark Pharmaceuticals Inc., USA$2K
  • plus $216 from 1 others

What the payments were for

  • Travel & lodging$2,15636%
  • Food & beverage$3,79864%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,954 in reported general payments places this provider in the 90th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$1,944,340
Medicare patients
392
Services billed
6,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine50$1,391
Doxycycline Hyclate38$677
Silver Sulfadiazine23$638
Clobetasol Propionate16$506
Prednisone13$11

Paid to pharmacies, not to this prescriber.

Other family medicine in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →